Abstract
Get full access to this article
View all access options for this article.
References
1.
Such conflicts include: Board of Directors Rohm & Haas Chemicals; Board of Directors Immune Response Corporation (Rhone-Poulenc-Rorer Chemicals is the major investor in the corporation); consultant to Proctor and Gamble, and expert witness defending the use of their new fat substitute, Olestra; advisory board Ecova Corporation (a hazardous waste clean-up company); and consultant to the Electric Power Research Institute and chairman of their Scientific Advisory Committee on EMFs, which has dismissed evidence of their adverse health effects.